Literature DB >> 871357

Metabolism of 14C-labelled alphaxalone in man.

L Strunin, J M Strunin, K M Knights, M E Ward.   

Abstract

The metabolism of 14C-labelled alphaxalone, dispensed as Althesin, was studied in normal patients, patients with obstructive jaundice and patients with chronic renal disease and anuria. The radioactive label was removed rapidly from the plasma following i.v. administration. The major portion of the label was excreted in the urine. In patients with normal renal function 14C-labelled alphaxalone is probably taken up by the liver, metabolized to a more polar compound and excreted in the urine; a small amount is excreted in the bile. In the patient with anuria, hepatic uptake appears to be relatively normal and the length of action of Althesin is not prolonged. It is assumed that in such patients the eventual route of excretion is via the bile and faeces.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871357     DOI: 10.1093/bja/49.6.609

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  A comparative assessment of alfathesin for use in outpatient anaesthesia.

Authors:  G L Dunn; P J Houlton; D H Morison; R Rajagopalan
Journal:  Can Anaesth Soc J       Date:  1978-03

2.  The pharmacological effects of the anesthetic alfaxalone after intramuscular administration to dogs.

Authors:  Jun Tamura; Tomohito Ishizuka; Sho Fukui; Norihiko Oyama; Kodai Kawase; Kenjiro Miyoshi; Tadashi Sano; Kirby Pasloske; Kazuto Yamashita
Journal:  J Vet Med Sci       Date:  2014-11-27       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.